The University of Florida Health Personalized Medicine Program has released "SNP-its" study summaries for pharmacogenomic articles with clinical relevance. The editorial team reviews articles from multiple journals and writes summaries for the ones most relevant to practicing clinicians. Those interested are welcome to subscribe to a monthly newsletter. Online, readers can browse summaries by topic. In the first newsletter, SNP-its highlights articles about
- CYP2C19 poor metabolizers may need a four-fold dose increase for clopidogrel
- CYP2D6 drug interactions may decrease response to hydrocodone and increase response to ondansetron
- personalized medicine in cardiology and oncology in Europe.
PharmGKB is pleased to work with the SNP-its initiative to highlight articles with these summaries on our website in the coming weeks. Look for the SNP-its icon on PharmGKB!
